Enhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pH-sensitive liposomes

被引:27
作者
Düzgünes, N
Simoes, S
Slepushkin, V
Pretzer, E
Rossi, JJ
De Clercq, E
Antao, VP
Collins, ML
de Lima, MCP
机构
[1] Univ Pacific, Dept Microbiol, San Francisco, CA 94115 USA
[2] Univ Coimbra, Pharmaceut Technol Lab, P-3000 Coimbra, Portugal
[3] Univ Coimbra, Ctr Neurosci, P-3000 Coimbra, Portugal
[4] Univ Coimbra, Dept Biochem, P-3000 Coimbra, Portugal
[5] Beckman Res Ctr City Hope, Dept Biol Mol, Duarte, CA 91010 USA
[6] Chiron Corp, Emeryville, CA 94608 USA
[7] Katholieke Univ Leuven, Rega Inst, Louvain, Belgium
关键词
D O I
10.1081/NCN-100002327
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An antisense oligodeoxynucleotide against the human immunodeficiency virus type 1 (HIV-1) Rev response element, a ribozyme complementary to the HIV-1 5'-LTR, and the reverse transcriptase inhibitors 9-(2-phosphonylmethoxyethyl) adenine (PMEA) and(R)-9-(2-phosphonylmethoxypropyl)-adenine (PMPA) inhibited virus replication in monocyte-derived macrophages more effectively when delivered in pH-sensitive liposomes compared to the free drugs.
引用
收藏
页码:515 / 523
页数:9
相关论文
共 39 条
[1]   Anti-HIV therapy with antisense oligonucleotides and ribozymes: Realistic approaches or expensive myths? [J].
Akhtar, S ;
Rossi, JJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (02) :159-165
[2]   SUBCUTANEOUS ADMINISTRATION OF LIPOSOMES - A COMPARISON WITH THE INTRAVENOUS AND INTRAPERITONEAL ROUTES OF INJECTION [J].
ALLEN, TM ;
HANSEN, CB ;
GUO, LSS .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1150 (01) :9-16
[3]  
[Anonymous], 1993, J LIPOSOME RES, DOI DOI 10.3109/08982109309148213]
[4]   ACTIVITY OF ACYCLIC NUCLEOSIDE PHOSPHONATE ANALOGS AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS IN MONOCYTE MACROPHAGES AND PERIPHERAL-BLOOD LYMPHOCYTES [J].
BALZARINI, J ;
PERNO, CF ;
SCHOLS, D ;
DECLERCQ, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 178 (01) :329-335
[5]  
BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
[6]  
Cantin E M, 1993, Trends Microbiol, V1, P270, DOI 10.1016/0966-842X(93)90050-2
[7]   INHIBITION OF PROTEIN-KINASE C-ALPHA EXPRESSION IN MICE AFTER SYSTEMIC ADMINISTRATION OF PHOSPHOROTHIOATE ANTISENSE OLIGODEOXYNUCLEOTIDES [J].
DEAN, NM ;
MCKAY, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11762-11766
[8]   ANTIVIRAL THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTIONS [J].
DECLERCQ, E .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (02) :200-239
[9]   Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells [J].
Düzgünes, N ;
Pretzer, E ;
Simoes, S ;
Slepushkin, V ;
Konopka, K ;
Flasher, D ;
de Lima, MCP .
MOLECULAR MEMBRANE BIOLOGY, 1999, 16 (01) :111-118
[10]   PHYSICOCHEMICAL CHARACTERIZATION OF LARGE UNILAMELLAR PHOSPHOLIPID-VESICLES PREPARED BY REVERSE-PHASE EVAPORATION [J].
DUZGUNES, N ;
WILSCHUT, J ;
HONG, K ;
FRALEY, R ;
PERRY, C ;
FRIEND, DS ;
JAMES, TL ;
PAPAHADJOPOULOS, D .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 732 (01) :289-299